Screener
Indivior Pharmaceuticals, Inc. INDV Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $3.72B.
The source filing: Indivior Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028850
FAQ
- What is Indivior Pharmaceuticals, Inc.'s market capitalization?
- Indivior Pharmaceuticals, Inc. (INDV) reported market capitalization of $3.72B in Q1 2026.
- How has Indivior Pharmaceuticals, Inc.'s market capitalization changed year-over-year?
- Indivior Pharmaceuticals, Inc.'s market capitalization increased by 212.8% year-over-year, from $1.19B to $3.72B.
- What is the long-term trend for Indivior Pharmaceuticals, Inc.'s market capitalization?
- Over 2 years (2023 to 2025), Indivior Pharmaceuticals, Inc.'s market capitalization has grown at a 47.9% compound annual growth rate (CAGR), from $2.05B to $4.49B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Indivior Pharmaceuticals, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude